Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron for Non-neurogenic Voiding Dysfunction in Children
NCT05240456Phase 2Unknown
- Sponsor
- Mansoura University
- Start
- Feb 2022
- Primary completion
- Jul 2022
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of mirabegron in Voiding dysfunction, sponsored by Mansoura University. Status: unknown.
02
Drugs
mirabegron
03
Conditions
Voiding dysfunction
Beyond the preview
Go deeper on NCT05240456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05240456.